Improving Outcomes in Individuals with COVID-19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial
- Granting Agency
- Canadian Institutes of Health Research
- Principal Investigators
- Birnie DH, Goodman SG, Liu PP
- Co-Investigators
- Chow Chi, Ezekowitz JA, Farkouh ME, Forster AJ, Healey JS, Lawler PR, Lee DS, Mcalister FA, McDonald EG, Oudit GY, Patel RV, Sharma A, So DY, Sun L, Tu K, Wells GA
- Grant Type
- COVID-19 Rapid Research Grant
- Grant Amount
- $1,176,019